WHO Includes the Cardiovascular Polypill in Its List of Essential Medicines After a Groundbreaking Study Led by the President of Mount Sinai Heart
August 03, 2023
August 03, 2023
NEW YORK, Aug. 3 (TNSres) -- Mount Sinai Hospital issued the following news release:
* * *
Medication can reduce cardiovascular mortality by 33 percent in patients treated after a heart attack
* * *
The cardiovascular polypill, developed by the Spanish National Centre for Cardiovascular Research (CNIC) and the pharmaceutical company Ferrer, has been included by the World Health Organization (WHO) in its List of Essential Medicines.
. . .
* * *
Medication can reduce cardiovascular mortality by 33 percent in patients treated after a heart attack
* * *
The cardiovascular polypill, developed by the Spanish National Centre for Cardiovascular Research (CNIC) and the pharmaceutical company Ferrer, has been included by the World Health Organization (WHO) in its List of Essential Medicines.
. . .